Background: Takotsubo syndrome is an increasingly recognized cause of chest pain and occasionally of cardiogenic shock. Despite rapid improvement of the left ventricular (LV) ejection fraction, recent registry data raise concerns about long-term prognosis. The aim of this study was to test the hypothesis that restoration of normal ejection fraction after acute takotsubo syndrome is not equivalent to full functional recovery.
Conclusions:
In patients with the most clinically severe spectrum of takotsubo cardiomyopathy, regional LV systolic and diastolic deformation abnormalities persist beyond the acute event, despite normalization of global LV ejection fraction and size. In addition, although myocardial edema partly subsides, a process of global microscopic fibrosis develops in its place, detected as early as 4 months. (J Am Soc Echocardiogr 2017;30:745-55.)
Keywords: Takotsubo, Stress cardiomyopathy, Echocardiography, Strain, Twist, Fibrosis, T1 mapping, Broken heart syndrome Acute stress-induced (takotsubo) cardiomyopathy has become much more readily recognized in recent years. Patients with takotsubo cardiomyopathy, which commonly masquerades as acute myocardial infarction, often have emotional or physical triggers and show no evidence of a coronary culprit or infarct-like myocardial scar on cardiac magnetic resonance (CMR) imaging. 1 The largest takotsubo registry in the world as well as data from the Swedish Cardiac Catheterisation Laboratory Registry demonstrate unequivocally that the mediumand long-term prognosis is not benign, and the mortality rate of takotsubo syndrome is comparable with that of myocardial infarction. 2, 3 Although this introduces a paradigm shift in how takotsubo syndrome's prognosis was viewed until recently, new important questions have arisen, with an urgent need to explain why a condition considered until recently as ''transient'' and ''naturally recovering'' portends such a poor outlook. It has become increasingly obvious that the relatively rapid recovery of left ventricular ejection fraction (LVEF), with or without right ventricular ejection fraction, after an acute attack of takotsubo cardiomyopathy is not paralleled by symptomatic 4 or electrocardiographic 5 recovery, for example. We have previously shown that acute takotsubo hearts demonstrate severe global edema associated with profound cardiac energetic impairment, with incomplete resolution of both at 4 months 6, 7 ; additionally, we showed persistently abnormal global longitudinal strain (GLS) at 3-month follow-up in a cohort of 36 patients with takotsubo cardiomyopathy comprising all comers (STsegment elevation, non-ST-segment elevation, normal electrocardiographic results, and all left ventricular [LV] ballooning subtypes [i.e., apical, midcavity, and basal]). 4 However, in a condition that shows that it is on its way to recovery on the basis of several clear objective assessments (normalized ejection fraction, decrease of myocardial edema), there remains a disproportionately high rate of persistent symptoms, as well as lack of return to work and physical activity, which do not appear to improve at the same rate as the objective indices. Because edema, energetic impairment, and an isolated reduction in GLS do not preclude the coexistence or recovery of a normal resting LVEF (which is different from LV performance), there must be additional pathophysiologic processes that intervene and, if present in the long term, could begin to explain the unexpected poor outcomes of these patients. Discrepancies in previous literature may have arisen because of a wide clinical spectrum of patients with takotsubo syndrome, variable follow-up, or both. The only way to further test the hypothesis of remaining uncovered pathology to explain this disproportionate persistence of symptoms relative to apparent recovery is to focus the investigation on a homogeneous and most clinically severe presenting spectrum of patients with takotsubo cardiomyopathy (ST-segment elevation, malignant arrhythmias on presentation, and large, apical extending into midcavity ballooning phenotype) and to look into all (systolic and diastolic) parameters of functional nonrecovery and mechanisms of potential longer lasting changes, such as myocardial fibrosis. Herein, we describe the 4-months follow-up recovery of LV myocardial deformation and structure in a prospectively recruited cohort of patients with takotsubo syndrome presenting with ST-segment elevation, left bundle branch block or malignant arrhythmias on electrocardiography, and LV apical ballooning subtype.
METHODS

Study Subjects
Consecutive consenting patients who met the takotsubo Mayo Clinic 1 and currently updated 8 criteria (pheochromocytoma and myocarditis excluded also) and who, in addition, demonstrated no evidence of late gadolinium enhancement on CMR imaging were prospectively recruited at Aberdeen Royal Infirmary between 2011 and 2016. All patients were initially suspected of having myocardial infarction, and most were brought in by Scottish Ambulance Service for primary percutaneous coronary intervention. All patients had either an emotional or no clear trigger, and we purposefully excluded patients with other concomitant physical triggers that could have confounded our findings; thus, patients with infections, inflammatory conditions, or any other concurrent physical illnesses potentially influencing myocardial findings in our judgement were not included in this report. All patients underwent coronary angiography and left ventriculography and had serial electrocardiography, 12-hour blood troponin I and brain natriuretic peptide assessment, and comprehensive echocardiography and contrast-enhanced CMR within 5 days of the onset of symptoms (the mean time from symptoms onset to first echocardiographic examination was 2 days and to first CMR was 3 days). LV recovery was assessed using comprehensive echocardiography and CMR at 4-month follow-up (mean, 122 6 5 days). To account for the effect of potential confounders, a control group of 44 subjects of similar age, gender, and comorbidity distribution (matching hypertension) were recruited and underwent a single-time-point echocardiographic assessment. The study was approved by the North of Scotland Research Ethics Committee and ran in accordance with the Declaration of Helsinki, and all subjects provided written informed consent.
Echocardiography
A comprehensive two-dimensional echocardiographic protocol was performed using commercially available systems (Vivid E9, equipped with a 2.5-MHz [M5S] transducer; GE Vingmed Ultrasound, Horten, Norway) by the same operator in all subjects (J.S.). All measurements were taken from the first echocardiographic study performed at presentation and the designated follow-up study at 4 months. Cine loops in standard parasternal long-axis, short-axis, and apical four-, three-, and two-chamber views were obtained at a frame rate of $85 Hz. Short-axis views of the left ventricle were taken at the mitral valve level (tip of the mitral valve leaflets), midventricular level (papillary muscle), and apical level (absence of papillary muscles). Three cardiac cycles in each view were obtained at endexpiratory breath-hold and stored for offline analysis. Conventional spectral Doppler parameters were recorded, such as early (E) and late (A) diastolic transmitral flow velocities, isovolumic relaxation time, and septal and lateral mitral annular early diastolic (E 0 ), late diastolic (A 0 ), and systolic (S 0 ) tissue velocities. All image analysis was performed offline using EchoPAC version 1.13 (GE Healthcare, Little Chalfont, United Kingdom) by two experienced operators (A.R. and J.S.). LVEF was calculated using the Simpson biplane method. 9 Speckle-tracking strain analysis was performed after manually adjusting the automatic detection of the epicardial and endocardial borders in each view and including all the apical myocardium (thus using an 18-segment model as opposed to the classical 17-segment one 10 ). The software provided segmental and global peak longitudinal, circumferential, and radial strain, from which GLS and basal, midcavity, and apical circumferential and radial strain were calculated. LV rotation of the basal and apical levels (shortaxis views) was calculated as the average angular displacement between the diastolic and systolic phases of the radial lines connecting the LV center to a specific epicardial point (Figure 1) . Rotation rates were defined as peak velocities of the respective clockwise (basal) or anticlockwise (apical) rotations as viewed from the apex.
11,12 LV twist (in degrees) was defined as the net difference between apical anticlockwise rotation and basal clockwise rotation. Torsion was defined as twist normalized to the base-to-apex LV length measured at end-diastole (in degrees per centimeter). 13, 14 Twist rate was calculated as the peak velocity of twist (in degrees per scond). 15 Early systolic ''propping'' twist (EST) was measured as the difference between the initial apical and basal rotation. 13 This early motion occurs during isovolumic contraction and is directed clockwise at the apex and counterclockwise at the base (thus opposite to the normal direction of movement to follow during systole, like an athlete throwing a discus who first turns to his right before spinning leftward to throw); this early motion is thought to have a role in ''propping'' the myocardium for effective systolic twist. 13 Similarly, diastolic apical and basal reverse rotation was measured as the peak clockwise and counterclockwise diastolic reverse rotations of the LV short-axis cross-sections, respectively. Untwist rate was determined from the rotational rate curve as the peak of the first negative deflection following aortic valve closure, as previously described. 16 The times to peak rotation, reverse rotation, peak twist, peak EST, and peak untwist were measured from the peak of the R wave. To correct for any differences in heart rate, for all temporal analyses, the R-R interval was normalized to 100%. The interobserver reproducibility for speckletracking LV mechanics was 5 6 2% (LV twist and GLS), 6 6 2% (EST), and 3 6 1% (untwist), each performed in n = 50 studies (20 with acute takotsubo syndrome, 20 at 4-month follow-up, and 10 control subjects by J.S. and A.R.). The intraobserver variability was 4 6 2% (LV twist and GLS), performed in all subjects included in this study (J.S.).
A typical LV strain curve in a normal heart is shown in Figures 2A and 2D.
Cardiac Magnetic Resonance
A 3-TAchieva scanner (Philips, Best, The Netherlands) was used for CMR imaging. The protocol included cine imaging, early and late gadolinium enhancement (Gadovist 0.1 mmol/kg; Bayer Schering Pharma, Berlin, Germany) with swap of the phase-encoding direction and pre-and postcontrast modified Look-Locker imaging T1 mapping. 17 Data for T1 mapping were acquired with 3(3)3(3)5 and 5(3)3 schemes for native and postcontrast T1 measurement, respectively, the latter at exactly 15 min after contrast administration. All CMR images were each analyzed by a pair of two independent expert observers (T.A., C.S., A.R., C.J.N.) blinded to each other, to the other imaging modality, and for T1 mapping to the order of the scan. The CMR images were analyzed in CMR Tools (Cardiovascular Imaging Solutions, London, United Kingdom) for computation of LV volumes and mass. Each segment was scored for functional status (1 = normal, 2 = hypokinetic, 3 = akinetic, 4 = dyskinetic). T1 maps were generated using Philips RelaxMaps tool and quality-controlled with goodness-of-fit maps (c 2 ). These were imported into Segment (Medviso, Lund, Sweden), in which T1 values were output for each of the 16 segments of the 17-segment model 10 (omitting the true apex), and myocardial extracellular volume (ECV) was calculated as previously described. 6 Our inter-and intraobserver variabilities for all T1 mapping analysis were 2.7 6 1.5% and 1.5 6 0.5%, respectively, and the interstudy variability for native T1 mapping in healthy volunteers was 2 6 0.5%.
Statistical Analysis
Data are expressed as mean 6 SD for normally distributed data and otherwise as medians and interquartile ranges. Continuous variables were checked for normality of distribution using the Shapiro-Wilk test. Differences between acute presentation and follow-up data were examined with the paired Student's t test or Wilcoxon matched-pairs signed rank test as appropriate. Patient data at followup were compared with those of control subjects using unpaired tests (unpaired Student's t test or Mann-Whitney U test). Categorical variables were analyzed using c 2 test or Fisher's exact test as appropriate. To account for multiple comparisons, the P value chosen for statistical significance was Bonferroni-adjusted depending on the number of variables compared between groups, after which significance was chosen at P < .05. Data were analyzed using the GraphPad Prism version 5 (GraphPad Software, San Diego, CA) and SPSS version 24 (SPSS, Chicago, IL). Variability was calculated as mean 6 SD of the ratios between differences and means of the two independently measured variables and expressed as a percentage. Table 1 shows the patients' and control subjects' demographic and general clinical characteristics. The majority (79%) presented with chest pain, and 87% had stressful triggers. From the initial 52 acutely presenting patients, 44 returned for follow-up. Four patients died (two of cardiogenic shock during acute admission, one of arrhythmic cardiac arrest, and one of subsequent suicide), and four patients underwent automated implantable defibrillator or pacing device implantation (one with ventricular fibrillation and long-QT syndrome, one with asystole after direct-current cardioversion for paroxysmal atrial fibrillation, and two with complete heart block, one of them preceding the takotsubo acute event; these were excluded from imaging follow-up because pacing is likely to affect strain data and were unsuitable for CMR). All medications commenced for presumed acute myocardial infarction were stopped as soon as the diagnosis of takotsubo cardiomyopathy was established (i.e., after coronary angiography and CMR provided a clear-cut diagnosis). Our center's takotsubo management policy for the duration of this enrollment was to not extrapolate on therapies used in other conditions with different pathophysiology (i.e., myocardial infarction) in the absence of any available evidence on the basis of ''primum non nocere.'' During their convalescence, patients continued only on the preexisting medical therapy for any comorbidities, except if LVEF was <50% at discharge, in which case angiotensin-converting enzyme inhibitors were continued empirically. The control subjects were of the same age and gender distribution, had similar cardiac comorbidities, and were on similar medications. Patients with takotsubo cardiomyopathy had a significantly higher heart rate, both acutely and at follow-up (P = .001 for both), although their heart rates were within normal physiologic limits (Tables 1 and 2 ).
RESULTS
Demographics
LV Strain and Twist at Presentation versus Follow-Up
As shown in Table 2 , there were marked abnormalities in most echocardiographic variables measured at acute presentation. Global indices of systolic and diastolic function such as LVEF and volumes as well as tissue Doppler indices of systolic (S 0 ) and diastolic (E 0 , E/E 0 ) function were abnormal upon presentation and improved significantly at follow-up (P < .05 for all) ( Table 2 ). There were significant abnormalities at presentation compared with follow-up in LV strain (Table 3) : GLS, midcavity radial and circumferential strain, and apical radial and circumferential strain (P < .05 all). Figure 3 shows a typical example of changes in apical circumferential strain. Similarly, there were significant changes in the LV twist mechanics. First, at presentation, 26% of patients with takotsubo cardiomyopathy lacked EST, usually seen in normal hearts, whereas this loss was less prevalent at follow-up (4%). In six patients (12%) during the acute presentation, the main systolic apical rotation was inverted (clockwise rather than counterclockwise). Apart from one patient, the direction of the main apical rotation normalized in all patients. In those with preserved direction of apical rotation in the acute phase, the degree of rotation was reduced (P = .029 vs follow-up), and the time to peak apical rotation was also reduced (P = .002 vs follow-up). Although basal rotation was not acutely affected, time to peak basal rotation was reduced as well (P = .014). Importantly, the magnitude of LV twist and torsion showed no significant improvement from presentation to follow-up, although time to peak LV twist improved. Similarly, during diastole, the untwist rate remained severely reduced, and further, time to peak untwist remained significantly delayed compared with control subjects.
LV Strain and Twist at Follow-Up versus Control Subjects
Recovery was assessed at 4-month follow-up in comparison with control subjects (Tables 2 and 3) . Global LVEF and end-systolic volume improved (P < .0001 by both echocardiography and CMR) and normalized in all but two patients. Despite the ''normal LVEF,'' subtle persistent wall motion abnormalities remained visible in 26 patients and were all confined to the territories affected during the acute phase. These subtle wall motion abnormalities were unlike the classical reduction in wall thickening seen in ischemic myocardium but were best seen as a reduction in the counterclockwise rotation of the apical short axis (which contributes to the heart's effective twist) or a slight delay in systolic contraction of some of the apical segments in long- axis views. Tissue Doppler parameters (S 0 , E 0 ) were no longer significantly different from those in control subjects, although there was a trend toward a delayed isovolumic relaxation time (P = .07) in patients with takotsubo cardiomyopathy. LV strain indices showed persistently impaired GLS and apical circumferential strain (P < .01 for both). Apical and basal rotation, their rates, and times to peak all improved and were nonsignificantly different from control subjects at followup, but their overall contribution was not enough to restore LV twist and torsion to normal values, which remained significantly impaired at follow-up compared with control subjects (P < .01 for both). The same was observed for time to peak EST, which remained significantly prolonged in the convalescent patients with takotsubo syndrome (P = .01). These systolic alterations were accompanied by residual diastolic abnormalities (i.e., reduced untwist rate and prolonged time to peak untwist rate in convalescent patients with takotsubo syndrome compared with control subjects; P < .01 for both). Figure 2 shows LV twist and untwist and rotational rates alterations seen in a typical patient with takotsubo syndrome acutely ( Figures 2B and 2E ) and at follow-up ( Figures 2C and 2F ) compared with a normal control subject (Figures 2A and 2C) . Importantly, there were no significant differences in any of the systolic or diastolic strain parameters between those patients with and those without visual wall motion abnormalities, underscoring the fact that these changes are subtle and poorly detected by the human eye above a certain threshold.
Myocardial Structure by CMR and T1 Mapping
CMR characteristics are shown in Table 2 and demonstrated a reduction in LV mass at follow-up (P < .001). Figure 4 demonstrates that significant increases in both native T1 and ECV values were seen acutely in both normally contracting and dysfunctional segments compared with control subjects: T1 = 1,238 6 64.5 and 1,292 6 80.6 msec (normal and dysfunctional) versus 1,189 6 16 msec (control) (P < .001 for both) and ECV = 0.327 6 0.038 and 0.326 6 0.040 (normal and dysfunctional) versus 0.273 6 0.045 (control) (P < .001 for both). Although native T1 normalized only in previously normally contracting segments at 4-month follow-up (T1 = 1,180 6 40.6 msec [normal, P = .2 vs control] and T1 = 1,208 6 60.3 msec [dysfunctional, P < .05 vs control]), ECV remained significantly abnormal in all LV segments (whether normally contracting [0.328 6 0.043, P < .001] or ballooning during acute presentation [0.320 6 0.044, P < .001], both vs control).
DISCUSSION
In this study, we comprehensively assessed LV strain, twist mechanics, and myocardial structure at presentation and 4-month follow-up in a homogeneously defined cohort of patients with takotsubo syndrome presenting predominantly with ST-segment elevation-type electrocardiographic findings or malignant arrhythmias and with the apical ballooning phenotype. This cohort was prospectively recruited, is the largest of its kind undergoing this analysis to date, was matched to control subjects, and included male patients. The main findings of this study, incremental to previous reports, are as follows:
Significant alterations in cardiac deformation, timing, and rates of contraction and relaxation persisted at 4-month follow-up after takotsubo cardiomyopathy compared with control subjects, despite normalization of LVejection fraction and volumes (systole: GLS, apical circumferential strain, LV twist, twist rate, and torsion; diastole: untwist rate and time to peak untwisting).
After an acute takotsubo episode, although myocardial edema partly subsides, a process of global microscopic fibrosis develops in its place, detected as early as 4 months.
Present Results in the Context of Previous Literature
Previous studies are at variance regarding the recovery in regional LV strain at early follow-up (1 month), with one study reporting persistence of postsystolic shortening 18 and another study highlighting that patients with ST-segment elevation-type presentation may have delayed recovery, especially of diastolic function. 16 Both of these casecontrol studies found an overwhelming improvement in most parameters studied. However, in a separate, earlier cohort of patients, we documented reduced GLS 3 months after the acute phase (a finding replicated by others at 21-day follow-up 19 ), associated with incomplete resolution of symptoms in a large proportion of patients with takotsubo syndrome. 4 In further separate takotsubo cohorts, we previously described additional persistent abnormalities, such as elevated Figure 4 Extracellular expansion in acute and recovered takotsubo cardiomyopathy. Native T1 and ECV in dysfunctional and normally contracting segments compared with control subjects acutely and at follow-up. *P < .001, acute versus control; † P < .05, follow-up versus control. natriuretic peptide concentrations at 3 months, persistent myocardial edema at 3 months, 20 and impaired myocardial energetic status (together with persistence of edema) at 4-month follow-up. 7 These objective abnormalities indicate that complete recovery in these patients may not occur as rapidly as previously thought and together with the persistent symptoms that we consistently observed during the clinical follow-up of these patients prompted us to reevaluate cardiac mechanics. A longer convalescent period or incomplete recovery after an acute takotsubo episode would better explain the recent registries' data, which place the long-term prognosis of takotsubo cardiomyopathy at a comparable level of that of myocardial infarction. 2, 3, 21 Furthermore, the apical ballooning subtype of takotsubo syndrome studied here has been recently shown to have the least favorable outcome of all takotsubo variants. 22 Indeed, in the present study, focused on the ''apical ballooning'' phenotype, presenting with either ST-segment elevation electrocardiographic findings, left bundle branch block, or malignant arrhythmias (thus defining a more severe clinical presenting spectrum), we demonstrate lack of recovery for several indices of systolic and diastolic performance, over and above the isolated finding of persistently abnormal GLS alone reported in previous studies inclusive of all comers. 4 Therefore, our study provides an important mechanistic explanation to support these large outcome studies. This is the first study to examine the architectural recovery of the LV myocardium after a takotsubo event, using contrast-enhanced CMR. The increased LV mass 23 is presumably a reflection of the significant myocardial edema seen in the myocardium during the acute stage, previously reported by us and others. 7, 20, 24 There is extensive evidence that precontrast T1 mapping is reflective of edema, previously provided by our group 25 and by others. [26] [27] [28] Here we replicate our previous findings 7 showing that LV edema subsides in the previously well-contracting segments. However, despite a significant decrease by 4 months after acute presentation, edema persists to a mild degree in the previously dysfunctional segments, in which precontrast T1 mapping values remain significantly elevated compared with a group of control subjects matched for age, gender, and hypertensive comorbidity. We also show that the extracellular component within the LV myocardium (expressed as a percentage of LV mass) is elevated acutely and remains at similar level at 4-month follow-up. Because the extent and severity of edema subsides during this time, it follows that something else must take its place: we believe that given that the ECV values do not change, this must reflect deposition of microscopic fibrosis that develops during the convalescent phase.
Unique Characteristics of Our Cohort
Several characteristics make the present study unique and bring added value to the currently published literature in this condition. First, it included a larger number of patients (this time including male patients as well) who are of a homogeneous, most clinically severe spectrum of takotsubo presentation. Second, our patients were not on b-blockers at follow-up, which is a unique cohort relative to the significant clinical equipoise present worldwide. Third, our control subjects were matched for cardiac comorbidities (mostly history of hypertension). The latter two characteristics eliminate important confounders in assessing LV strain and twist mechanics, which are known to be affected by inotropic therapy [29] [30] [31] [32] [33] and LV afterload. 34, 35 Importance and Extent of Systolic, Diastolic, and Extracellular Matrix Abnormalities
The alterations in LV twist mechanics were seen both as reduced mechanical performance (reduced strain and twist) and as significant shifts in the timing of events. First, the systolic changes span from a complete disappearance of EST (which is a novel finding) to a reduction in LV rotation that paradoxically peaks earlier than normal, further on to a complete reversal of rotational direction. It is not clear if these alterations carry different prognostic implications. The earlier occurrence of peak rotating motion may reflect blunting of overall contraction or may represent an adaptive mechanism to the reduction in global longitudinal function (most marked during the acute phase). Importantly, these alterations result in an ineffective LV twist, which remains abnormal in the convalescent phase at 4 months and matches findings of impaired longitudinal and apical circumferential strain.
The diastolic abnormalities were equally striking: in both acute and convalescent takotsubo cardiomyopathy, we found a reduced untwisting rate that peaked late during diastole (on average by 20-60 msec compared with control subjects). These abnormalities are likely to lead to alterations in diastolic function and filling. Importantly, this reduced ability of the myocardium to relax persisted at 4-month follow-up, despite normalization of global functional parameters (LVEF, mitral annular S 0 , E 0 , and E/E 0 ), and is a novel finding of this study. Moreover, they make it unlikely that the acute findings are due to the Q-T prolongation seen acutely in this condition, because the Q-T interval recovered in all patients at 4-month follow-up (data not shown). It is surprising therefore that classical parameters such as E 0 and E/E 0 were no longer different at follow-up compared with control subjects. Perhaps the explanation lies in the fact that the alterations seen in takotsubo syndrome are more subtle or of a different nature compared with other cardiomyopathies. Indeed, these mechanotemporal alterations in the convalescent takotsubo hearts are present despite an apparent preservation of LV geometry, as none of the patients included in this study showed any evidence of macroscopic fibrosis (scar) on CMR. Although these findings were observed using resting echocardiography, it is not known how these parameters would change with exercise, but it is conceivable that they provide at least a partial explanation for recent reports of fatigue and inability to engage in physical exercise in these patients. 4 The patients with takotsubo syndrome in this study appeared to sustain relative resting tachycardia compared with control subjects. There are at least two possible explanations: given the mechanotemporal disruption of LV mechanics, the higher heart rate may represent a compensatory mechanism for maintaining effective cardiac output. Another possibility is that these patients may have associated autonomic dysfunction, with parasympathetic failure, as recently suggested, 36 or the two conditions may coexist. This is an important balance to establish with respect to guiding future therapies, because in one instance b-blockers may be useful, whereas in the other they may be harmful in counteracting an adaptive mechanism.
The ECV values in themselves are comparable with those reported in other heart conditions, such as postmyocarditis, cardiomyopathies, and diabetic heart, and thus it is unlikely that ECV would have any quantitative value in differentiating the post-takotsubo heart from other conditions. 37, 38 The real significance of our findings is the striking lack of return to a normal myocardial structure in a condition considered until recently as ''a fully reversible form of acute cardiomyopathy.'' Finally, our findings raise the need for longer term studies. They also may have implications for functional recovery (e.g., exercise capacity and the possibility that these patients are candidates for developing heart failure with preserved ejection fraction) and for the development of effective therapy: if a process of myocardial fibrosis persists after takotsubo cardiomyopathy, then the case for specific disease-modifying therapy to prevent long-term damage is strengthened. Alternatively, antifibrotic therapies could be considered in future studies to explore if the medium-and long-term prognosis of these patients may be improved by such interventions.
CONCLUSIONS
We demonstrate persistence of subtle LV systolic and diastolic abnormalities at 4-month follow-up in the most severe spectrum of acute stress-induced (takotsubo) cardiomyopathy, despite apparent normalization of LVEF, compared with control subjects of similar age, gender, and comorbidity distribution. In addition, although myocardial edema partly subsides, a process of global microscopic fibrosis develops in its place, detected as early as 4 months. This suggests either a longer recovery phase in this group or that this condition may not be fully reversible, as previously thought. This is important in the context of therapy decision making acutely and beyond the initial period of LVEF recovery. Studies investigating potential therapies are needed.
